{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:55:50Z","timestamp":1767916550342,"version":"3.49.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1005914","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000}}],"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Commission Seventh Framework Programme","doi-asserted-by":"crossref","award":["ITN-264780"],"award-info":[{"award-number":["ITN-264780"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011102","name":"European Commission Seventh Framework Programme","doi-asserted-by":"crossref","award":["ITN-264780"],"award-info":[{"award-number":["ITN-264780"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011102","name":"European Commission Seventh Framework Programme","doi-asserted-by":"crossref","award":["ITN-264780"],"award-info":[{"award-number":["ITN-264780"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011102","name":"European Commission Seventh Framework Programme","doi-asserted-by":"crossref","award":["ITN-264780"],"award-info":[{"award-number":["ITN-264780"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011102","name":"European Commission Seventh Framework Programme","doi-asserted-by":"crossref","award":["ITN-264780"],"award-info":[{"award-number":["ITN-264780"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Governmjavascript:ent and the European Union FEDER funds","award":["SAF2014-56059-R"],"award-info":[{"award-number":["SAF2014-56059-R"]}]},{"name":"Spanish Government and the European Union FEDER funds","award":["SAF2015-70270-REDT"],"award-info":[{"award-number":["SAF2015-70270-REDT"]}]},{"name":"Spanish Government and the European Union FEDER funds","award":["SAF2015-66984-C2-1-R"],"award-info":[{"award-number":["SAF2015-66984-C2-1-R"]}]},{"name":"Generalitat de Catalunya-AGAUR","award":["2014SGR1017"],"award-info":[{"award-number":["2014SGR1017"]}]},{"name":"ICREA Academia"},{"name":"Lend\u00fclet Program of the Hungarian Academy of Sciences"},{"DOI":"10.13039\/100010269","name":"Welcome Trust","doi-asserted-by":"crossref","award":["098016\/Z\/11\/Z"],"award-info":[{"award-number":["098016\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005914","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T19:10:29Z","timestamp":1514920229000},"page":"e1005914","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells"],"prefix":"10.1371","volume":"14","author":[{"given":"Igor","family":"Mar\u00edn de Mas","sequence":"first","affiliation":[]},{"given":"Esther","family":"Aguilar","sequence":"additional","affiliation":[]},{"given":"Erika","family":"Zodda","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-5538","authenticated-orcid":true,"given":"Cristina","family":"Balcells","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Marin","sequence":"additional","affiliation":[]},{"given":"Guido","family":"Dallmann","sequence":"additional","affiliation":[]},{"given":"Timothy M.","family":"Thomson","sequence":"additional","affiliation":[]},{"given":"Bal\u00e1zs","family":"Papp","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Cascante","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1055-9965.EPI-09-1310","article-title":"Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999\u20132001","volume":"19","author":"SF Altekruse","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref2","first-page":"S0302","article-title":"Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level","author":"T Karantanos","year":"2014","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fonc.2014.00142","article-title":"Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment","volume":"4","author":"M Renovanz","year":"2014","journal-title":"Front Oncol"},{"key":"ref4","first-page":"201367","article-title":"Tumor heterogeneity: the lernaean hydra of oncology?","author":"M Janiszewska","year":"2014","journal-title":"Oncology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canlet.2015.04.025","article-title":"Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines","volume":"364","author":"Y Kondaveeti","year":"2015","journal-title":"Cancer Lett"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2796.2011.02493.x","article-title":"Systems medicine and metabolic modelling","volume":"271","author":"A Mardinoglu","year":"2012","journal-title":"J Intern Med"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4155\/fmc.14.119","article-title":"Cancer cell metabolism as new targets for novel designed therapies","volume":"6","author":"Igor Mar\u00edn de Mas","year":"2014","journal-title":"Future Med Chem"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1172\/JCI59218","article-title":"Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells","volume":"122","author":"T Celi\u00e0-Terrassa","year":"2012","journal-title":"J Clin Invest"},{"issue":"26","key":"ref10","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.2174\/092986711796957310","article-title":"Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved","volume":"18","author":"S Serini","year":"2011","journal-title":"Curr Med Chem"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nbt.2488","article-title":"A community-driven global reconstruction of human metabolism","volume":"31","author":"I Thiele","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"24","key":"ref12","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1093\/bioinformatics\/btq602","article-title":"iMAT: an integrative metabolic analysis tool","volume":"26","author":"H Zur","year":"2010","journal-title":"Bioinformatics"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nbt.1487","article-title":"Network-based prediction of human tissue-specific metabolism","volume":"26","author":"T Shlomi","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/stem.2286","article-title":"Metabolic landscape and vulnerabilities of metastatic prostate epithelial cancer stem cells independent of epithelial-mesenchymal transition","volume":"34","author":"E Aguilar","year":"2016","journal-title":"Stem Cells"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1158\/1535-7163.MCT-14-0183","article-title":"Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer","volume":"3","author":"IR Schlaepfer","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"ref16","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/0008-5472.CAN-12-3797","article-title":"Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma","volume":"73","author":"K Muir","year":"2013","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"ref17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.prostaglandins.2010.07.002","article-title":"Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression","volume":"93","author":"S Koontongkaew","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"22","key":"ref18","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3748\/wjg.v19.i22.3423","article-title":"Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma","volume":"19","author":"SY Liu","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-011-1768-8","article-title":"C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth","volume":"133","author":"M Flowers","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"42","key":"ref20","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1038\/onc.2012.523","article-title":"Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth","volume":"32","author":"V Fritz","year":"2013","journal-title":"Oncogene"},{"issue":"14","key":"ref21","first-page":"4258","article-title":"Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression","volume":"63","author":"GP Pidgeon","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/en.2012-2074","article-title":"TGF-\u03b2 effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3 K\/AKT\/mTOR pathway","volume":"154","author":"BT Vo","year":"2013","journal-title":"Endocrinology"},{"issue":"19","key":"ref23","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1158\/0008-5472.CAN-07-6689","article-title":"Prostaglandin E2 regulates tumor angiogenesis in prostate cancer","volume":"68","author":"S Jain","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.mce.2013.11.014","article-title":"Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells","volume":"382","author":"E Munetsuna","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"4A","key":"ref25","first-page":"2551","article-title":"Vitamin D compounds: clinical development as cancer therapy and prevention agents","volume":"26","author":"DL Trump","year":"2006","journal-title":"Anticancer Res"},{"issue":"4","key":"ref26","first-page":"761","article-title":"Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies","volume":"37","author":"H Lin","year":"2010","journal-title":"Int J Oncol"},{"issue":"19","key":"ref27","doi-asserted-by":"crossref","first-page":"e12977","DOI":"10.14814\/phy2.12977","article-title":"Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men","volume":"4","author":"Ribel\u2010Madsen Amalie","journal-title":"Physiol Rep."},{"issue":"1\u20132","key":"ref28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(02)00432-9","article-title":"Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice","volume":"187","author":"T Kato","year":"2002","journal-title":"Cancer Letters"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1111\/j.1742-4658.2006.05292.x","article-title":"Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1","volume":"273","author":"SA Sch\u00f8nberg","year":"2006","journal-title":"The FEBS Journal"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/pros.20830","article-title":"Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway","volume":"68","author":"IA Shaikh","year":"2008","journal-title":"Prostate"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/biof.181","article-title":"Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects","volume":"37","author":"RA Siddiqui","year":"2011","journal-title":"Biofactors"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1515\/CCLM.2008.323","article-title":"Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes","volume":"46","author":"I. Unterwurzacher","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2144\/000112517","article-title":"ImageJ for microscopy","volume":"43","author":"TJ Collins","year":"2007","journal-title":"BioTechniques"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ijo.2012.1588","article-title":"Arachidonic acid metabolism in human prostate cancer","volume":"41","author":"P Yang","year":"2012","journal-title":"International Journal of Oncology"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1097-0045(19990501)39:2<87::AID-PROS2>3.0.CO;2-Z","article-title":"SensibarCytotoxic sensitivity to tumor necrosis factor-\u03b1 in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin)","volume":"39","author":"M. Sintich Sharon","year":"1999","journal-title":"Prostate"},{"issue":"3\u20134","key":"ref36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-011-9297-9","article-title":"The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis","volume":"30","author":"P Ekambaram","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biocel.2014.11.004","article-title":"Role of intracellular prostaglandin E\u2082 in cancer-related phenotypes in PC3 cells","volume":"59","author":"A Madrigal-Mart\u00ednez","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"issue":"17","key":"ref38","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s00018-015-1891-5","article-title":"Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells","volume":"72","author":"AB Fern\u00e1ndez-Mart\u00ednez","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"ref39","first-page":"3150","article-title":"Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells","volume":"9","author":"ST Palayoor","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref40","first-page":"105","article-title":"Tumor heterogeneity: causes and consequences","volume":"1805","author":"A Marusyk","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"A Carracedo","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2217\/17460875.3.4.453","article-title":"Roles of Eicosanoids in Prostate Cancer","volume":"3","author":"K Nithipatikom","year":"2008","journal-title":"Future Lipidol"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbamcr.2008.09.008","article-title":"Lysosomal involvement in cell death and cancer","volume":"1793","author":"T Kirkegaard","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1194\/jlr.M032375","article-title":"Acid ceramidase as a therapeutic target in metastatic prostate cancer","volume":"54","author":"L Camacho","year":"2013","journal-title":"J Lipid Res"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.canep.2010.03.019","article-title":"COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67","volume":"34","author":"E Richardsen","year":"2010","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/sj.ki.5000137","article-title":"Relationship between 12\/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy","volume":"69","author":"ZG Xu","year":"2006","journal-title":"Kidney Int"},{"issue":"9","key":"ref47","first-page":"2721","article-title":"Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells","volume":"62","author":"GP Pidgeon","year":"2002","journal-title":"Cancer Res"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd4145","article-title":"Metabolic targets for cancer therapy","volume":"12","author":"L Galluzzi","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"RA Irizarry","year":"2003","journal-title":"Biostatistics"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"e34670","DOI":"10.1371\/journal.pone.0034670","article-title":"Identification of Functional Differences in Metabolic Networks Using Comparative Genomics and Constraint-Based Models","volume":"7","author":"JJ Hamilton","year":"2012","journal-title":"PLoS ONE"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-8-421","article-title":"A procedure for the estimation over time of metabolic fluxes in scenarios where measurements are uncertain and\/or insufficient","volume":"8","author":"F Llaneras","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1101\/gr.2546004","article-title":"Genome-scale in silico models of e. coli have multiple equivalent phenotypic states: assessment of correlated reaction subsets that comprise network states","volume":"14","author":"JL Reed","year":"2004","journal-title":"Genome Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ymben.2003.09.002","article-title":"The effects of alternate optimal solutions in constraint-based genome-scale metabolic models","volume":"5","author":"R Mahadevan","year":"2003","journal-title":"Metabolic Engineering"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2105-12-28","article-title":"FASIMU: flexible software for flux-balance computation series in large metabolic networks","volume":"12","author":"A Hoppe","year":"2011","journal-title":"BMC Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1005914","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T18:15:14Z","timestamp":1660241714000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005914"}},"subtitle":[],"editor":[{"given":"Nathan E","family":"Lewis","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005914","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1005914","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,2]]}}}